Patent: 8,058,418
✉ Email this page to a colleague
Summary for Patent: 8,058,418
Title: | Polynucleotides encoding heavy and light chains of antibodies to OPGL |
Abstract: | Compositions comprising polynucleotides encoding heavy and light chains of antibodies that interact with osteoprotegerin ligand (OPGL) are described. Methods of making such antibodies are described. |
Inventor(s): | Boyle; William J. (Thousand Oaks, CA), Martin; Francis H. (Newbury Park, CA), Corvalan; Jose R. (Foster City, CA), Davis; C. Geoffrey (Burlingame, CA) |
Assignee: | Amgen Inc. (Thousand Oaks, CA) Amgen Fremont Inc. (Fremont, CA) |
Application Number: | 11/981,664 |
Patent Claims: | see list of patent claims |
Details for Patent 8,058,418
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Amgen, Inc. | PROLIA | denosumab | Injection | 125320 | 06/01/2010 | ⤷ Try a Trial | 2021-06-26 |
Amgen, Inc. | XGEVA | denosumab | Injection | 125320 | 11/18/2010 | ⤷ Try a Trial | 2021-06-26 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 8,058,418
Country | Patent Number | Estimated Expiration |
---|---|---|
South Africa | 200400521 | ⤷ Try a Trial |
Yugoslavia | 103003 | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 03002713 | ⤷ Try a Trial |
United States of America | 8409578 | ⤷ Try a Trial |
United States of America | 7364736 | ⤷ Try a Trial |
United States of America | 2020354464 | ⤷ Try a Trial |
United States of America | 2020131271 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |